Registry of patients undergoing transcatheter aortic valve implantation in Kazakhstan
TAVI Registry at the National Research Center for Cardiac Surgery, Astana, Kazakhstan
NA · National Research Center for Cardiac Surgery, Kazakhstan · NCT06874465
This study looks at patients in Kazakhstan who have had aortic valve surgery to see how well they do and how their quality of life changes over time.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | National Research Center for Cardiac Surgery, Kazakhstan (other) |
| Locations | 1 site (Astana) |
| Trial ID | NCT06874465 on ClinicalTrials.gov |
What this trial studies
This registry analyzes patients with aortic stenosis who have undergone transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) in Kazakhstan. The study aims to collect and compare outcomes, including survival rates, complications, and quality of life, over a follow-up period of up to four years. It will also assess the prevalence of aortic stenosis in different regions of Kazakhstan and evaluate the effectiveness of TAVI compared to SAVR. This is the first systematically collected database for TAVI in Central Asia.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with severe symptomatic aortic stenosis who are undergoing TAVI.
Not a fit: Patients with active endocarditis or a recent history of cerebrovascular events may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the outcomes of TAVI in the Kazakhstani population, potentially improving patient care and treatment strategies.
How similar studies have performed: While this approach is novel for Central Asia, similar registries in other regions have shown success in improving patient outcomes and understanding of TAVI.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients has given written informed Concent for study participation prior to procedure * Patients with Aortic Valve stenosis * Patients has severe degenerative or congenital aortic stenosis. * Patients has symptomatic aortic stenosis as demonstrated by NYHA II or greater Exclusion Criteria: * Patients has active endocarditis * Patients has history of cerebral vascular accident or transient ischemic attack within the past 3 months
Where this trial is running
Astana
- National Research Center for Cardiac Surgery — Astana, Kazakhstan (RECRUITING)
Study contacts
- Study coordinator: Abdurashid Mussayev, PhD
- Email: abdurashid.mussayev@gmail.com
- Phone: +77029997667
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Aortic Valve Stenosis